Pancreatic Cancer Research

Journal articleAm J Clin Oncol2021

Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.

Journal
Am J Clin Oncol
Published
1 June 2021
Citations
3
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Objectives Low rates of participation in cancer clinical trials are commonly reported, raising concerns about missed opportunities to engage patients in treatment trials. We reviewed eligibility for and enrollment in pancreatic cancer clinical trials for patients seen at a National Cancer Institute (NCI)-designated cancer center during 1 year, to calculate participation rates with detailed information to determine the best-case participation rate. … Excerpt only: this text is the publisher’s. Read it in full at the source.